基于医院的熟练护理设施生存率:组织和市场水平的预测因素
Health care management review
|August 5, 2024
概括
大型非营利性医院和竞争性较低的市场的医院技术护理设施 (HBSNF) 显示出更高的生存率. 这一发现有助于管理员在为HBSNF连续性分配资源.
科学领域:
- 医疗保健管理的管理
- 组织生态学 组织生态学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 医疗保健支付改革,包括前性支付系统 (PPS),影响了医院对熟练护理设施 (SNF) 的所有权.
- 尽管补偿政策发生了变化,但许多医院仍在继续运营医院技术护理设施 (HBSNF).
研究的目的:
- 调查影响HBSNF生存的组织和市场因素.
- 应用组织人口生态的框架来理解HBSNF的持久性.
主要方法:
- 美国医院协会对1998年至2020年美国急症护理医院的调查数据进行分析,这些医院在1998年至2020年期间有HBSNF.
- 使用Cox回归来确定HBSNF关闭风险的事件历史分析.
- 关键变量包括医院规模,所有权,财务利,市场竞争和医疗保险优势透率.
主要成果:
- 大型非营利性医院的HBSNF显示生存率增加.
- 在竞争较弱的市场中,HBSNF的寿命更长.
- 医院的大小和所有权显著影响了HBSNF生存率.
结论:
- 研究结果表明,医院的规模和所有权,以及市场竞争,是HBSNF生存的关键决定因素.
- 管理人员可以利用这些见解来战略性地分配资源,特别是在竞争性市场内的小型营利性设施中.
- 保持HBSNF与监管对护理连续性的重视一致.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
239
06:52Assessment of Dependence in Activities of Daily Living Among Older Patients in an Acute Care Unit
Published on: September 30, 2020
9.7K
相关概念视频
Assumptions of Survival Analysis
114
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
114
Comparing the Survival Analysis of Two or More Groups
166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Cancer Survival Analysis
334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Actuarial Approach
69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Documentation in Long-Term and Home Healthcare Setting
875
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
875
Introduction To Survival Analysis
201
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
201
